- Home
- SIG vs APGE Comparison
SIG vs APGE Comparison
Compare SIG & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SIG | APGE |
|---|---|---|
| Founded | 1950 | 2022 |
| Country | Bermuda | United States |
| Employees | N/A | N/A |
| Industry | Consumer Specialties | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 4.7B |
| IPO Year | 1997 | 2023 |
Fundamental Metrics
Financial Performance| Metric | SIG | APGE |
|---|---|---|
| Price | $92.70 | $89.28 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 13 |
| Target Price | ★ $111.14 | $109.67 |
| AVG Volume (30 Days) | 918.4K | ★ 1.0M |
| Earning Date | 06-02-2026 | 05-11-2026 |
| Dividend Yield | ★ 1.50% | N/A |
| EPS Growth | ★ 974.07 | N/A |
| EPS | ★ 7.08 | N/A |
| Revenue | ★ $6,247,100,000.00 | N/A |
| Revenue This Year | $1.36 | N/A |
| Revenue Next Year | $1.71 | N/A |
| P/E Ratio | $13.20 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $52.14 | $31.60 |
| 52 Week High | $110.20 | $89.63 |
Technical Indicators
Market Signals| Indicator | SIG | APGE |
|---|---|---|
| Relative Strength Index (RSI) | 56.15 | 69.06 |
| Support Level | $89.54 | $73.06 |
| Resistance Level | $95.10 | N/A |
| Average True Range (ATR) | 3.59 | 3.42 |
| MACD | 1.01 | 0.61 |
| Stochastic Oscillator | 89.14 | 94.17 |
Price Performance
Historical ComparisonAbout SIG Signet Jewelers Limited
Signet Jewelers Ltd is a retailer of diamond jewelry. Its merchandise mix includes bridal, fashion, watches, and others. The bridal category includes engagement, wedding and anniversary purchases. Its segments are the North America segment, the International segment, and the Other segment. The North America segment contributes to the majority of the revenue. The North America segment generates revenue from Mall and Off-Mall & Outlet.
About APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.